Correction: Molecular response prediction in CML: novel ideas?

Dominik Wolf; Sieghart Sopper

doi:10.18632/oncotarget.26360

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Molecular response prediction in CML: novel ideas?

PDF | How to cite

Oncotarget. 2018; 9:35871-35871. https://doi.org/10.18632/oncotarget.26360

Metrics: PDF 999 views | ?

Dominik Wolf¹ and Sieghart Sopper²

¹ Department of Hematology, Oncology and Rheumatology, Center of Integrated Oncology Cologne Bonn, University Hospital of Bonn, Bonn, Germany
² Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria

Published: November 09, 2018

This article has been corrected: The added affiliation information is given below:

² Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria

Original article: Oncotarget. 2017; 8:80105-80106. DOI: https://doi.org/10.18632/oncotarget.21049.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26360

Publication Alerts

Corrections:

Correction: Molecular response prediction in CML: novel ideas?